Phase II study of caracemide in advanced or recurrent non-small cell lung cancer

Cancer Treat Rep. 1987 Nov;71(11):1099-100.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Diagnosis-Related Groups
  • Drug Evaluation
  • Female
  • Humans
  • Hydroxyurea / analogs & derivatives*
  • Hydroxyurea / therapeutic use
  • Lung Neoplasms / drug therapy*
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local

Substances

  • caracemide
  • Hydroxyurea